Currently out of the existing stock ratings of David Li, 1 are a BUY (12.5%), 7 are a HOLD (87.5%).

David Li

Work Performance Price Targets & Ratings Chart

Analyst David Li, carries an average stock price target met ratio of 100% that have a potential upside of 9.72% achieved within 39 days.

David Li’s has documented 17 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ZLAB, Zai Lab Ltd at 03-Mar-2025.

Wall Street Analyst David Li

Analyst best performing recommendations are on ZLAB (ZAI LAB LTD).
The best stock recommendation documented was for ZLAB (ZAI LAB LTD) at 3/3/2025. The price target of $36.1 was fulfilled within 4 days with a profit of $4.37 (13.77%) receiving and performance score of 34.43.

Average potential price target upside

BGNE BeiGene Ltd ZLAB Zai Lab Ltd

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 25-Feb-2019

$260

$75.29 (40.76%)

$260

1 years 3 months 15 days ago
(17-Dec-2024)

8/14 (57.14%)

$80.94 (45.20%)

133

Buy Since 03-Dec-2024

$300

$115.29 (62.42%)

1 years 3 months 29 days ago
(03-Dec-2024)

0/1 (0%)

$93.99 (45.62%)

Buy Since 20-Aug-2024

$235

$50.29 (27.23%)

$200

1 years 5 months 10 days ago
(22-Oct-2024)

4/5 (80%)

$14.37 (6.51%)

130

Buy Since 14-May-2019

$307

1 years 7 months 6 days ago
(26-Aug-2024)

12/24 (50%)

$113.18 (58.39%)

58

Buy Since 17-Jul-2023

$288

$103.29 (55.92%)

$285

1 years 7 months 24 days ago
(08-Aug-2024)

0/4 (0%)

$104.97 (57.35%)

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by David Li?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?